Pharmacological treatment of portal hypertension.
Patch
D
D
Department of Liver Transplantation and Hepato-Biliary Medicine, Royal Free Hospital, London, England.
Burroughs
A K
AK
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002404:Catheterization; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use; D004932:Esophageal and Gastric Varices / Q000188:drug therapy; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy* / Q000628:therapy; D008236:Lypressin / Q000031:analogs & derivatives / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D008981:Molsidomine / Q000627:therapeutic use; D015282:Octreotide / Q000627:therapeutic use; D011170:Portasystemic Shunt, Surgical; D015911:Sclerotherapy; D013004:Somatostatin / Q000627:therapeutic use; D000077585:Terlipressin; D014665:Vasodilator Agents / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D014665:Vasodilator Agents; D014667:Vasopressins; D008236:Lypressin; D013004:Somatostatin; D000077585:Terlipressin; D008981:Molsidomine; D008787:Metoclopramide; D015282:Octreotide